Vaccines for immunological control of fertility

Reproductive Medicine and Biology

Volumn 9, Issue 2, 2010, Pages 61-71

  Gupta, Satish K ^a   Bansal, Pankaj ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

Fertilization; Hormones; Immunocontraception; Spermatozoa; Vaccine zona pellucida

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; CONTRACEPTIVE VACCINE; EPITOPE; FOLLITROPIN; GLYCOPROTEIN; GONADORELIN;

FERTILITY; HUMAN; IMMUNIZATION; IMMUNOCONTRACEPTION; INFERTILITY; NONHUMAN; OVARY INFLAMMATION; POPULATION DYNAMICS; PRIORITY JOURNAL; REVIEW; SPERMATOGENESIS; ZONA PELLUCIDA;

EID: 77954886626     PISSN: 14455781     EISSN: 14470578     Source Type: Journal    
DOI: 10.1007/s12522-009-0042-9     Document Type: Review

References (115)

1. 2 emissions. Proc Natl Acad Sci USA. 1997;94:175-9.
2. Bradley MP, Bird P. Applications of fertility regulation for the management of wild and domestic species. In: Hardy DM, editor. Fertilization. San Diego: Academic; 2002. p. 401-15.
3. Cowan PE, Tyndale-Biscoe CH. Australian and New Zealand mammal species considered to be pests or problems. Reprod Fertil Dev. 1997;9:27-36.
4. White RB, Eisen JA, Kasten TL, Fernald RD. Second gene for gonadotropin releasing hormone in humans. Proc Natl Acad Sci USA. 1998;95:305-9.
5. Yahalom D, Chen A, Ben-Aroya N, Rahimipour S, Kaganovsky E, Okon E, et al. The gonadotrophin-releasing hormone family of neuropeptides in the brain of human, bovine and rat: identification of a third isoform. FEBS Lett. 1999;463:289-94.
6. Hodges JK, Hearn JP. Effects of immunization against lutein-izing hormone releasing hormone on reproduction of the marmoset monkey Callithrix jacchus. Nature. 1977;265:746-8.
7. Takahashi M, Ford JJ, Yoshinaga K, Greep RO. Active immunization of female rats with luteinizing hormone releasing hormone (LHRH). Biol Reprod. 1978;18:754-61.
8. Oonk HB, Turkstra JA, Schaaper WM, Erkens JH, Schuite-maker-de Weerd MH, van Nes A, et al. New GnRH-like peptide construct to optimize efficient immunocastration of male pigs by immunocontraception of GnRH. Vaccine. 1998;16:1074-82.
9. Miller LA, Johns BE, Killian GJ. Immunocontraception of white-tailed deer with GnRH vaccine. Am J Reprod Immunol. 2000;44:266-74.
10. Curtis PD, Pooler RL, Richmond ME, Miller LA, Mattfeld GF, Quimby FW. Comparative effects of GnRH and porcine zona pellucida (PZP) immunocontraceptive vaccines for controlling reproduction in white-tailed deer (Odocoileus virginianus). Reprod Suppl. 2002;60:131-41.
11. Jung MJ, Moon YC, Cho IH, Yeh JY, Kim SE, Chang WS, et al. Induction of castration by immunization of male dogs with recombinant gonadotropin-releasing hormone (GnRH)-canine distemper virus (CDV) T helper cell epitope p35. J Vet Sci. 2005;6:21-4.
12. Walker J, Ghosh S, Pagnon J, Colantoni C, Newbold A, Zeng W, et al. Totally synthetic peptide-based immunocontraceptive vaccines show activity in dogs of different breeds. Vaccine. 2007;25:711 1-9.
13. Junaidi A, Williamson PE, Cummins JM, Martin GB, Blackberry MA, Trigg TE. Use of a new drug delivery formulation of the gonadotrophin-releasing hormone analogue Deslorelin for reversible long-term contraception in male dogs. Reprod Fertil Dev. 2003;15:317-22.
14. Dunshea FR, Colantoni C, Howard K, McCauley I, Jackson P, Long KA, et al. Vaccination of boars with a GnRH vaccine (Improvac) eliminates boar taint and increases growth performance. J Anim Sci. 2001;79:2524-35.
15. Simms MS, Scholfield DP, Jacobs E, Michaeli D, Broome P, Humphreys JE, et al. Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer. Br J Cancer. 2000;83:443-6.
16. Parkinson RJ, Simms MS, Broome P, Humphreys JE, Bishop MC. A vaccination strategy for the long-term suppression of androgens in advanced prostate cancer. Eur Urol. 2004;45:171-5.
17. Moudgal NR, Ravindranath N, Murthy GS, Dighe RR, Ara-vindan GR, Martin F. Long-term contraceptive efficacy of vaccine of ovine follicle-stimulating hormone in male bonnet monkeys (Macaca radiata). J Reprod Fertil. 1992;96:91-102.
18. Moudgal NR, Jeyakumar M, Krishnamurthy HN, Sridhar S, Krishnamurthy H, Martin F. Development of male contraceptive vaccine-a perspective. Hum Reprod Update. 1997;3:335-46.
19. Moudgal NR, Murthy GS, Prasanna Kumar KM, Martin F, Suresh R, Medhamurthy R, et al. Responsiveness of human male volunteers to immunization with ovine follicle stimulating hormone vaccine: results of a pilot study. Hum Reprod. 1997;12:457-63.
20. Baskin MJ. Temporary sterilization by injection of human spermatozoa: a preliminary report. Am J Obstet Gynecol. 1932;24:892-7.
21. Edwards RG. Immunological control of fertility in female mice. Nature. 1964;203:50-3.
22. Ingerslev HJ. Antibodies against spermatozoal surface-membrane antigens in female infertility. Acta Obstet Gynecol Scand Suppl. 1981;100:1-52.
23. Ohl D, Naz RK. Infertility due to antisperm antibodies. J Urol. 1995;46:591-602.
24. Primakoff P, Lathrop W, Wollman L, Cowan A, Myles D. Fully effective contraception in male and female guinea pigs immunized with the sperm protein PH-20. Nature. 1988;335:543-7.
25. Herr JC, Flickinger CJ, Homyk M. Biochemical and morphological characterization of intra-acrosomal antigen SP-10 from human sperm. Biol Reprod. 1990;42:181-9.
26. Lea IA, van Lierop MJ, Widgren EE, Grootenhuis A, Wen Y, van Duin M. A chimeric sperm peptide induces antibodies and strain-specific reversible infertility in mice. Biol Reprod. 1998;59:527-36.
27. Hardy CM, Mobbs KJ. Expression of recombinant mouse sperm protein sp56 and assessment of its potential for use as an antigen in an immunocontraceptive vaccine. Mol Reprod Dev. 1999;52:216-24.
28. Zhu X, Naz RK. Fertilization antigen-1: cDNA cloning, testis-specific expression, and immunocontraceptive effects. Proc Natl Acad Sci USA. 1997;94:4704-9.
29. Suri A. Family of sperm associated antigens: relevance in sperm-egg interaction and immunocontraception. Soc Reprod Fertil Suppl. 2007;63:433-43.
30. Naz RK. The fertilization antigen (FA-1) causes a reduction of fertility in actively immunized female rabbits. J Reprod Immunol. 1987;11:117-33.
31. O'Hearn PA, Liang ZG, Bambra CS, Goldberg E. Colinear synthesis of an antigen-specific B-cell epitope with a 'promiscuous' tetanus toxin T-cell epitope: a synthetic peptide immu-nocontraceptive. Vaccine. 1997;15:1761-6.
32. Tollner TL, Overstreet JW, Branciforte D, Primakoff PD. Immunization of female cynomolgus macaques with a synthetic epitope of sperm-specific lactate dehydrogenase results in high antibody titres but does not reduce fertility. Mol Reprod Dev. 2002;62:257-64.
33. O'Rand MG, Widgren EE, Sivashanmugam P, Richardson RT, Hall SH, French FS, et al. Reversible immunocontraception in male monkeys immunized with Eppin. Science. 2004;306:1189-90.
34. Naz RK, Zhu X, Kadam AL. Identification of human sperm peptide sequence involved in egg binding for immunocontra-ception. Biol Reprod. 2000;62:318-24.
35. Naz RK, Chauhan SC. Human sperm-specific peptide vaccine that causes long-term reversible contraception. Biol Reprod. 2002;67:674-80.
36. Hardy CM, Pekin J, ten Have J. Mouse-specific immunocon-traceptive polyepitope vaccines. Reprod Suppl. 2002;60:19-30.
37. Naz RK. Immunocontraceptive effect of Izumo and enhancement by combination vaccination. Mol Reprod Dev. 2008;75:336-44.
38. Inoue N, Ikawa M, Isotani A, Okabe M. The immunoglobulin superfamily protein Izumo is required for sperm to fuse with eggs. Nature. 2005;434:234-8.
39. Wang M, Lv Z, Shi J, Hu Y, Xu C. Immunocontraceptive potential of the Ig-like domain of Izumo. Mol Reprod Dev. 2009;76:794-801.
40. Wassarman PM, Litscher ES. Mammalian fertilization: the egg's multifunctional zona pellucida. Int J Dev Biol. 2008;52:665-76.
41. Beebe SJ, Leyton L, Burks D, Ishikawa M, Fuerst T, Dean J, et al. Recombinant mouse ZP3 inhibits sperm binding and induces the acrosome reaction. Dev Biol. 1992;151:48-54.
42. Bleil JD, Wassarman PM. Mammalian sperm-egg interaction: identification of a glycoprotein in mouse egg zonae pelluci-dae possessing receptor activity for sperm. Cell. 1980;20:873-82.
43. Bleil JD, Greve JM, Wassarman PM. Identification of a secondary sperm receptor in the mouse egg zona pellucida: role in maintenance of binding of acrosome-reacted sperm to eggs. Dev Biol. 1988;128:376-85.
44. Izquierdo-Rico MJ, Jimenez-Movilla M, Llop E, Perez-Oliva AB, Ballesta J, Gutierrez-Gallego R, et al. Hamster zona pel-lucida is formed by four glycoproteins: ZP1, ZP2, ZP3 and ZP4. J Proteome Res. 2009;8:926-41.
45. Ganguly A, Sharma RK, Gupta SK. Bonnet monkey (Macaca radiata) ovaries, like human oocytes, express four zona pellu-cida glycoproteins. Mol Reprod Dev. 2008;75:156-66.
46. Hoodbhoy T, Joshi S, Boja ES, Williams SA, Stanley P, Dean J. Human sperm do not bind to rat zonae pellucidae despite the presence of four homologous glycoproteins. J Biol Chem. 2005;280:12721-31.
47. Hughes DC, Barratt CL. Identification of the true human orthologue of the mouse Zp1 gene: evidence for greater complexity in the mammalian zona pellucida? Biochim Biophys Acta. 1999;1447:303-6.
48. Lefievre L, Conner SJ, Salpekar A, Olufowobi O, Ashton P, Pavlovic B, et al. Four zona pellucida glycoproteins are expressed in the human. Hum Reprod. 2004;19:1580-6.
49. Chakravarty S, Kadunganattil S, Bansal P, Sharma RK, Gupta SK. Relevance of glycosylation of human zona pellucida gly-coproteins for their binding to capacitated human spermatozoa and subsequent induction of acrosomal exocytosis. Mol Reprod Dev. 2008;75:75-88.
50. Chiu PC, Wong BS, Chung MK, Lam KKK, Pang RT, Lee KF, et al. Effects of native human zona pellucida glycoprotein-3 and-4 on acrosome reaction and zona pellucida binding of human spermatozoa. Biol Reprod. 2008;79:869-77.
51. Caballero-Campo P, Chirinos M, Fan XJ, Gonzaáez-Gonzaáez ME, Galicia-Chavarriá M, Larrea F, et al. Biological effects of recombinant human zona pellucida proteins on sperm function. Biol Reprod. 2006;74:760-8.
52. Chakravarty S, Kadunganattil S, Gupta SK. Baculovirus-expressed recombinant human zona pellucida glycoprotein-B induces acrosomal exocytosis in capacitated spermatozoa in addition to zona pellucida glycoprotein-C. Mol Hum Reprod. 2005;11:365-72.
53. Sacco AG, Yurewicz EC, Subraminian MG, DeMayo FJ. Zona pellucida composition: species cross reactivity and contraceptive potential of antiserum to a purified pig zona antigen (PPZA). Biol Reprod. 1981;25:997-1008.
54. Wood DM, Liu C, Dunbar BS. Effect of alloimmunization and heteroimmunization with zona pellucidae on fertility in rabbits. Biol Reprod. 1981;25:439-50.
55. Mahi-Brown CA, Huang TT Jr, Yanagimachi R. Infertility in bitches induced by active immunization with porcine zonae pellucidae. J Exp Zool. 1982;222:89-95.
56. Gulyas BJ, Yuan LC, Gwatkin RB, Schmell ED. Response of monkeys to porcine zona pellucida as detected by a solid-phase radioimmunoassay. J Med Primatol. 1983;12:331-42.
57. Sacco AG, Pierce DL, Subramanian MG, Yurewicz EC, Duke-low WR. Ovaries remain functional in squirrel monkeys (Sai-miri sciureus) immunized with porcine zona pellucida 55, 000 macromolecule. Biol Reprod. 1987;36:481-90.
58. Sacco AG, Yurewicz EC, Subramanian MG. Effect of varying dosage and adjuvants on antibody response in squirrel monkeys (Saimiri sciureus) immunized with the porcine zona pellucida Mr = 55, 000 glycoprotein (ZP3). Am J Reprod Immunol. 1989;21:1-8.
59. Upadhyay SN, Thillai-Koothan P, Bamezai A, Jayaraman S, Talwar GP. Role of adjuvants in inhibitory influence of immunization with porcine zona pellucida antigen (ZP3) on ovarian folliculogenesis in bonnet monkeys: a morphological study. Biol Reprod. 1989;41:665-73.
60. Bagavant H, Thillai-Koothan P, Sharma MG, Talwar GP, Gupta SK. Antifertility effects of porcine zona pellucida-3 immunization using permissible adjuvants in female bonnet monkeys (Macaca radiata): reversibility, effect on follicular development and hormonal profiles. J Reprod Fertil. 1994;102:17-25.
61. Paterson M, Wilson MR, Morris KD, van Duin M, Aitken RJ. Evaluation of the contraceptive potential of recombinant human ZP3 and human ZP3 peptides in a primate model: their safety and efficacy. Am J Reprod Immunol. 1998;40:198-209.
62. Martinez ML, Harris JD. Effectiveness of zona pellucida protein ZPB as an immunocontraceptive antigen. J Reprod Fertil. 2000;120:19-32.
63. Govind CK, Gupta SK. Failure of female baboons (Papio anu-bis) to conceive following immunization with recombinant non-human primate zona pellucida glycoprotein-B expressed in Escherichia coli. Vaccine. 2000;18:2970-8.
64. Govind CK, Srivastava N, Gupta SK. Evaluation of the immu-nocontaceptive potential of Escherichia coli expressed recom-binant non-human primate zona pellucida glycoproteins in homologous animal model. Vaccine. 2002;21:78-88.
65. Lou AM, Garza KM, Hunt D, Tung KS. Antigen mimicry in autoimmune disease sharing of amino acid residues critical for pathogenic T cell activation. J Clin Invest. 1993;92:2117-23.
66. Hinsch E, Hagele W, Bohle RM, Schill WB, Hinsch KD. Evaluation of ZP2 domains of functional importance with antisera against synthetic ZP2 peptides. J Reprod Fertil. 1998;114:245-51.
67. Sun W, Lou YH, Dean J, Tung KS. A contraceptive peptide vaccine targeting sulfated glycoprotein ZP2 of the mouse zona pellucida. Biol Reprod. 1999;60:900-7.
68. Hasegawa A, Hamada Y, Shigeta M, Koyama K. Contraceptive potential of synthetic peptides of zona pellucida protein (ZPA). J Reprod Immunol. 2002;53:91-8.
69. Sivapurapu N, Upadhyay A, Hasegawa A, Koyama K, Gupta SK. Native zona pellucida reactivity and in vitro effect on human sperm-egg binding with antisera against bonnet monkey ZP1 and ZP3 synthetic peptides. J Reprod Immunol. 2002;56:77-91.
70. Ringleb J, Rohleder M, Jewgenow K. Impact of feline zona pellucida glycoprotein B-derived synthetic peptides on in vitro fertilization of cat oocytes. Reproduction. 2004;127:179-86.
71. Lou Y, Ang J, Thai H, McElveen F, Tung KS. A zona pellucida 3 peptide vaccine induces antibodies and reversible infertility without ovarian pathology. J Immunol. 1995;155:2715-20.
72. Paterson M, Wilson MR, Jennings ZA, van Duin M, Aitken RJ. Design and evaluation of a ZP3 peptide vaccine in a homologous primate model. Mol Hum Reprod. 1999;5:342-52.
73. Kaul R, Sivapurapu N, Afzalpurkar A, Srikanth V, Govind CK, Gupta SK. Immunocontraceptive potential of recombinant bonnet monkey (Macaca radiata) zona pellucida glycoprotein-C expressed in Escherichia coli and its corresponding synthetic peptide. Reprod Biomed Online. 2001;2:33-9.
74. Miller LA, Killian GJ. In search of the active PZP epitope in white-tailed deer immunocontraception. Vaccine. 2002;20:2735-42.
75. Hardy CM, ten Have JF, Mobbs KJ, Hinds LA. Assessment of the immunocontraceptive effect of a zona pellucida 3 peptide antigen in wild mice. Reprod Fertil Dev. 2002;14:151-5.
76. Sivapurapu N, Hasegawa A, Gahlay GK, Koyama K, Gupta SK. Efficacy of antibodies against a chimeric synthetic peptide encompassing epitopes of bonnet monkey (Macaca radiata) zona pellucida-1 and zona pellucida-3 glycoproteins to inhibit in vitro human sperm-egg binding. Mol Reprod Dev. 2005;70:247-54.
77. Sivapurapu N, Upadhyay A, Hasegawa A, Koyama K, Gupta SK. acy of antibodies against Escherichia coli expressed chimeric recombinant protein encompassing multiple epitopes of zona pellucida glycoproteins to inhibit in vitro human sperm-egg binding. Mol Reprod Dev. 2003;65:309-17.
78. Hardy CM, Clydesdale G, Mobbs KJ. Development of mouse-specific contraceptive vaccines: infertility in mice immunized with peptide and polyepitope antigens. Reproduction. 2004;128:395-407.
79. Hardy CM, Beaton S, Hinds LA. Immunocontraception in mice using repeated, multi-antigen peptides: immunization with purified recombinant antigens. Mol Reprod Dev. 2008;75:126-35.
80. Kirkpatrick JF, Liu IKK, Turner JW Jr. Remotely-delivered immunocontraception in feral horses. Wildl Soc Bull. 1990;18:326-30.
81. Kirkpatrick JF, Zimmermann W, Kolter L, Liu IKK, Turner JN. Immunocontraception of captive exotic species. I. Przewalski's horse (Equus przewalskii) and banteng (Bos javanacus). Zoo Biol. 1995;14:403-13.
82. McShea WJ, Monfort SL, Hakim S, Kirkpatrick JF, Liu IKK, Turner JW, et al. Immunocontraceptive efficacy and the impact of contraception on the reproductive behaviors of white-tailed deer. J Wildl Manag. 1997;61:560-9.
83. Kirkpatrick JF, Turner A. Reversibility of action and safety during pregnancy of immunization against porcine zona pellu-cida in wild mares (Equus caballus). Reprod Suppl. 2002;60:197-202.
84. Kirkpatrick JF, Turner A. Absence of effects from immuno-contraception on seasonal birth patterns and foal survival among barrier island wild horses. J Appl Anim Welf Sci. 2003;6:301-8.
85. Curtis PD, Richmond ME, Miller LA, Quimby FW. Patho-physiology of white-tailed deer vaccinated with porcine zona pellucida immunocontraceptive. Vaccine. 2007;25:4623-30.
86. Fayrer-Hosken RA, Grobler D, Van Altena JJ, Bertschinger HJ, Kirkpatrick JF. Immunocontraception of African elephants. Nature. 2000;407:149.
87. Srivastava N, Santhanam R, Sheela P, Mukund S, Thakral SS, Malik BS, et al. Evaluation of the immunocontraceptive potential of Escherichia coli-expressed recombinant dog ZP2 and ZP3 in a homologous animal model. Reproduction. 2002;123:847-57. (Pubitemid 34662061)
88. Turner JW Jr, Liu IK, Kirkpatrick JF. Remotely delivered im-munocontraception in free-roaming feral burros (Equus asinus). J Reprod Fertil. 1996;107:31-5.
89. Brown RG, Bowen WD, Eddington JD, Kimmins WC, Mezei M, Parsons JL, et al. Evidence for a long-lasting single administration contraceptive vaccine in wild grey seals. J Reprod Immunol. 1997;35:43-51.
90. Choudhury S, Kakkar V, Suman P, Chakrabarti K, Vrati S, Gupta SK. Immunogenicity of zona pellucida glycoprotein-3 and spermatozoa YLP (12) peptides presented on Johnson grass mosaic virus-like particles. Vaccine. 2009;27:2948-53.
91. Zhang X, Lou YH, Koopman M, Doggett T, Tung KS, Curtiss R 3rd. Antibody responses and infertility in mice following oral immunization with attenuated Salmonella typhimurium expressing recombinant murine ZP3. Biol Reprod. 1997;56:33-41.
92. Jackson RJ, Maguire DJ, Hinds LA, Ramshaw IA. Infertility in mice induced by a recombinant ectromelia virus expressing mouse zona pellucida glycoprotein 3. Biol Reprod. 1998;58:152-9.
93. Lloyd ML, Shellam GR, Papadimitriou JM, Lawson MA. Immunocontraception is induced in BALB/c mice inoculated with murine cytomegalovirus expressing mouse zona pellucida 3. Biol Reprod. 2003;68:2024-32.
94. Gu W, Holland M, Janssens P, Seamark R, Kerr P. Immune response in rabbit ovaries following infection of a recombinant myxoma virus expressing rabbit zona pellucida protein B. Virology. 2004;318:516-23.
95. Rath A, Choudhury S, Hasegawa A, Koyama K, Gupta SK. Antibodies generated in response to plasmid DNA encoding zona pellucida glycoprotein-B inhibit in vitro human sperm-egg binding. Mol Reprod Dev. 2002;62:525-33.
96. Rath A, Batra D, Kaur R, Vrati S, Gupta SK. Characterization of immune response in mice to plasmid DNA encoding dog zona pellucida glycoprotein-3. Vaccine. 2003;21(17-18): 1913-23.
97. Choudhury S, Ganguly A, Chakrabarti K, Sharma RK, Gupta SK. DNA vaccine encoding chimeric protein encompassing epitopes of human ZP3 and ZP4: immunogenicity and characterization of antibodies. J Reprod Immunol. 2009;79:137-47.
98. Li J, Jin H, Zhang A, Li Y, Wang B, Zhang F. Enhanced contraceptive response by co-immunization of DNA and protein vaccines encoding the mouse zona pellucida 3 with minimal oophoritis in mouse ovary. J Gene Med. 2007;9:1095-103.
99. Fishel SB, Edwards RG, Evans CJ. Human chorionic gonado-tropin secreted by preimplantation embryos cultured in vitro. Science. 1984;223:816-8.
100. Stenman UH, Alfthan H, Hotakainen K. Human chorionic gonadotropin in cancer. Clin Biochem. 2004;37:549-61.
101. Stevens VC, Powell JE, Lee AC, Griffin D. Antifertility effects of immunization of female baboons with C-terminal peptides of the beta-subunit of human chorionic gonadotropin. Fertil Steril. 1981;36:98-105.
102. Stevens VC. Progress in the development of human chorionic gonadotropin antifertility vaccines. Am J Reprod Immunol. 1996;35:148-55.
103. Jones WR, Bradley J, Judd SJ, Denholm EH, Ing RM, Mueller UW, et al. Phase I clinical trial of a World Health Organisation birth control vaccine. Lancet. 1988;1(8598):1295-8.
104. Rock EP, Reich KA, Lyu DM, Hovi M, Hardy J, Schoolnik GK, et al. Immunogenicity of a fusion protein linking the beta sub-unit carboxyl terminal peptide (CTP) of human chorionic gon-adotropin to the B subunit of Escherichia coli heat-labile enterotoxin (LTB). Vaccine. 1996;14:1560-8.
105. Cui C, Stevens VC, Schwendeman SP. Injectable polymer microspheres enhance immunogenicity of a contraceptive pep-tide vaccine. Vaccine. 2007;25:500-9.
106. Talwar GP, Sharma NC, Dubey SK, Salahuddin M, Das C, Ramakrishnan S, et al. Isoimmunization against human chori-onic gonadotropin with conjugates of processed beta-subunit of the hormone and tetanus toxoid. Proc Natl Acad Sci USA. 1976;73:218-22.
107. Nash H, Johansson ED, Talwar GP, Vasquez J, Segal S, Cout-inho E, et al. Observations on the antigenicity and clinical effects of a candidate antipregnancy vaccine: beta-subunit of human chorionic gonadotropin linked to tetanus toxoid. Fertil Steril. 1980;34:328-35.
108. Gaur A, Arunan K, Singh O, Talwar GP. Bypass by an alternate carrier of acquired unresponsiveness to hCG upon repeated immunization with tetanus conjugated vaccine. Int Immunol. 1990;2:151-5.
109. Gupta A, Pal R, Ahlawat S, Bhatia P, Singh O. Enhanced Immunogenicity of a contraceptive vaccine using diverse synthetic carriers with permissible adjuvant. Vaccine. 2001;19:3384-9.
110. Talwar GP, Singh O, Pal R, Chatterjee N, Sahai P, Dhall K, et al. A vaccine that prevents pregnancy in women. Proc Natl Acad Sci USA. 1994;91:8532-6.
111. Singh M, Das SK, Suri S, Singh O, Talwar GP. Regain of fertility and normality of progeny born during below protective threshold antibody titers in women immunized with the HSDhCG vaccine. Am J Reprod Immunol. 1998;39:395-8.
112. Ehrlich PH, Bernard MP, Myers RV, Macdonald GJ, Moyle WR. Epitope-specific focusing of the immune response to a minimized human chorionic gonadotropin analog. Biochem Biophys Res Commun. 1998;247:315-8.
113. Chiesa MD, Martensen PM, Simmins C, Porakishvili N, Justesen J, Dougan G, et al. Refocusing of B cell response following a single amino acid substitution in an antigen. Immunology. 2001;103:172-8.
114. Porakishvili N, Chiesa MD, Chikadze N, Martensen PM, Justensen J, Lund T, et al. Elimination of the luteinizing hormone cross-reactive epitopes from human chorionic gonadotropin. Vaccine. 2002;20:2053-9.
115. Wang XL, Zhao XR, Yu M, Yuan MM, Yao XY, Li DJ. Gene conjugation of molecular adjuvant C3d3 to hCGbeta increased the anti-hCG beta Th2 and humoral immune response in DNA immunization. J Gene Med. 2006;8:498-505.